Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
MedRespond
AddedFeb 16, 2024
UpdatedJun 18, 2026
MedRespond

MedRespond

Seed

MedRespond: Simplifying online healthcare through effective conversation solutions.

HQ
Pittsburgh, PA, US
Founded
2000
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize healthcare communication, MedRespond leverages artificial intelligence to provide interactive and personalized content. The company's core vision is to simplify online healthcare interactions, making them as effective as in-person conversations. MedRespond offers a customizable virtual education platform designed to enhance patient safety and streamline communication for patients, clinicians, and administrators. Their market focus includes healthcare providers, educational institutions, and patient support services.

MedRespond has garnered attention through its innovative approach to healthcare communication, attracting notable investors and partnerships within the healthcare and technology sectors. The company has achieved significant milestones in improving patient engagement and clinician efficiency, contributing positively to the overall healthcare experience. By integrating AI-driven solutions, MedRespond has set a new standard for virtual healthcare education and communication, impacting numerous patients and healthcare professionals globally.

MedRespond - Similar Companies

MedChat logo

MedChat

medchatapp.com

My Own Med logo

My Own Med

myownmed.com

medEchat logo

medEchat

medechat.com

MDconnectME logo

MDconnectME

MedBridge logo

MedBridge

medbridge.com

MedWhat logo

MedWhat

medwhat.com

Mederva Health logo

Mederva Health

medervahealth.com

Medifies logo

Medifies

medifies.com

OnMed logo

OnMed

onmed.com

Mdcapsule logo

Mdcapsule

VocoMD logo

VocoMD

RxVantage logo

RxVantage

rxvantage.com

Medoctor logo

Medoctor

Bot MD logo

Bot MD

botmd.io

MedAux logo

MedAux

MedRespond - Quick Facts

Who are MedRespond's competitors?

Companies similar to MedRespond include MedChat, My Own Med, medEchat and MDconnectME.

When was MedRespond founded?

MedRespond was founded in 2000.

Where is MedRespond's headquarters located?

MedRespond's headquarters is located in Pittsburgh, PA, US.

When was MedRespond's last funding round?

MedRespond's most recent funding round was for $50k (USD) in July 2020.

How much has MedRespond raised to-date?

As of Jul 28, 2020, MedRespond has raised a total of $50k (USD).

How many employees does MedRespond have?

MedRespond has 7 employees as of Feb 4, 2024.

MedRespond - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Telemedicine
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Small Business
Main Product
  • Education
  • Healthcare
Tags
  • Healthtech
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software